Kusurinomadoguchi, Inc.

Kusurinomadoguchi, Inc. , located in Tokyo, Japan, provides essential pharmaceutical and healthcare services, focusing on the distribution of medications and wellness products to enhance patient access and ensure compliance with healthcare standards. Founded in 2004, Kusurinomadoguchi, Inc. operates primarily in the pharmaceutical distribution sector, catering to both B2B and B2C markets.

The company has successfully completed a total of 3 deals, with their most recent deal occurring in October 2023. The firm is headquartered in Tokyo, Japan. Kusurinomadoguchi specializes in providing a comprehensive range of pharmaceutical and healthcare-related services, including the distribution of prescription medications, over-the-counter drugs, and various health and wellness products. The company focuses on enhancing patient access to essential medications while ensuring that clients adhere to healthcare regulations and safety standards.

Their services streamline the procurement process for healthcare providers, ensuring timely delivery and availability of necessary medications. Kusurinomadoguchi primarily operates within the Japanese market but may also extend services to international clients seeking reliable pharmaceutical partnerships. Kusurinomadoguchi generates revenue primarily through direct sales of its pharmaceutical products to retailers and healthcare providers. The business model includes B2B and B2C transactions, with partnerships in place for bulk purchasing agreements that facilitate procurement for clients.

Revenue is driven by the volume of prescriptions filled and the recurring nature of healthcare product sales, with tailored pricing plans for different client segments. In October 2023, Kusurinomadoguchi, Inc. raised JPY 4. 76 billion in an IPO, selling 2.

8 million shares at JPY 1,700 per share at the Growth Market, valuing the company at JPY 18. 67 billion. The funds raised will support the launch of new pharmaceutical products and enhance distribution capabilities. The company aims to expand its operations to international markets by 2025, focusing on partnerships that will allow them to reach a broader consumer base.